Dr. Loveman is a senior lecturer in the Department of Finance at Harvard Business School and was named the first recipient of the School's Apgar Award for excellence and innovation in teaching. Loveman earned a PhD in economics from the Massachusetts Institute of Technology.
About Ellipsis Health
Ellipsis Health has pioneered an artificial intelligence-powered, speech-based vital sign to quantify and manage depression and anxiety symptoms at scale. With depression and anxiety symptoms impacting one third of Americans and costing the global society over $1 trillion each year, Ellipsis Health's integrated behavioral health solution helps healthcare providers and payors reliably identify and evaluate high-risk patient populations. Machine-learning algorithms assess patient speech through cloud-based deep learning models and generate an automated assessment of anxiety and depression symptoms for clinical decision support. To learn more about the HIPAA-compliant platform facilitating behavioral health screening or longitudinal monitoring of symptoms for depression and anxiety, please visit www.ellipsishealth.com or contact Susan Solinsky, Chief Growth Officer, susan@ellipsishealth.com.
Back to HCB News
